Lupin gets 6 observations from USFDA for its Pithampur Unit-2

The inspection of Pithampur Unit -2 was carried out by the United States Food and Drug administration (USFDA) between January 14 and January 25, 2019.

from Healthcare/Biotech-Industry-Economic Times http://bit.ly/2CNJj4o
via IFTTT